444 related articles for article (PubMed ID: 28776339)
1. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
3. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
4. Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.
Lee SO; Lee JE; Lee S; Lee SH; Kang JS; Son H; Lee H; Kim J
Sci Rep; 2022 Jun; 12(1):9974. PubMed ID: 35705675
[TBL] [Abstract][Full Text] [Related]
5. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
7. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
8. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
[TBL] [Abstract][Full Text] [Related]
9. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
[TBL] [Abstract][Full Text] [Related]
10. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.
Kim SE; Jung Y; Oh TH; Kim UJ; Kang SJ; Jang HC; Park KH; Lee KH; Jung SI
BMC Cancer; 2018 Nov; 18(1):1080. PubMed ID: 30409111
[TBL] [Abstract][Full Text] [Related]
11. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological trends and therapeutic challenges of malignancies in adult HIV-1-infected patients receiving combination antiretroviral therapy in a tertiary hospital from Romania: An observational retrospective study.
Gheorghiță V; Conea IF; Radu AMC; Ștefan I; Mărdărescu M; Petrea S; Streinu-Cercel A
J Infect Public Health; 2019; 12(2):182-189. PubMed ID: 30344102
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
14. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
15. Non-AIDS-defining cancers among HIV-infected people.
Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
[TBL] [Abstract][Full Text] [Related]
16. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
18. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
20. Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era.
Sharma SK; Soneja M; Ranjan S
Indian J Med Res; 2015 Nov; 142(5):563-7. PubMed ID: 26658591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]